By Rock Health’s count, 302 investment firms and “notable angels” put money into a digital health startup in 2013. Twenty-seven of them did it three or more times.
That’s a big jump from the eight who did three or more deals in 2012. An influx of digital health exits, final guidance from the FDA on mobile apps, more good opportunities or any number of other factors may have led investors to pony up capital for more of these companies last year.
However, a few who topped this list last year, like Aberdare and NEA, laid low this year.
Here are the digital health investors who did the most deals in 2013:
- The Social+Capital Partnership – 7 investments, including Asthmapolis, Breakthrough, NeuroTrack and Syapse
- Norwest Venture Partners (NVP) – 6 investments, including Misfit Wearables, Basis Science and iRhythm
- Cardinal Partners – 4 investments, including QPID and Vitals
- Khosla Ventures – 4 deals, including HealthTap, Misfit Wearables and Jawbone
- Merck Global Health Innovation Fund – 4 deals, including Medivo, Aviir and PatientSafe Solutions
- Qualcomm Ventures – 4 investments, including Practice Fusion
The following firms did three deals each:
- BlueCross BlueShield Venture Partners
- DCM
- Excel Venture
- First Round Capital
- FirstMark Capital
- Google Ventures
- Heritage Group
- HLM
- InterCapital
- KPCB
- Lemhi Ventures
- Lerer Ventures
- Mayfield Fund
- MemorialCare
- Milestone VP
- Noro-Moseley
- Safeguard Scientifics
- Sandbox Industries
- Sequoia Capital
- Venrock
- West Health
The Funding Model for Cancer Innovation is Broken — We Can Fix It
Closing cancer health equity gaps require medical breakthroughs made possible by new funding approaches.
For more on digital health funding in 2013, read this morning’s post or check out Rock Health’s full end-of-year report.